HDT Bio Corp.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2041
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 23, 2026The maintenance fee for Compositions and Methods for Delivery of RNA (US 11,654,200) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
- 1 fee due Dec 20, 2026The maintenance fee for Compositions and methods for delivery of RNA (US 11,679,163) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Nucleic Acid-Small Diameter and Liquid Core Nanoparticle Complexed Compositions (US 11,752,218) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due Aug 13, 2027The maintenance fee for Compositions and Methods for Delivery of RNA (US 11,896,677) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,318,213 | Compositions and Methods for Delivery of RNA In force · Medium confidence | In force | Medium confidence | |
| US 11,376,335 | RNA-Lipid Nanoparticle Complexes of Viral RNA Polymerase Region and SARS-CoV-2 Spike Protein Region. In force · Medium confidence | In force | Medium confidence | |
| US 11,433,142 | Compositions and Methods for Delivery of RNA-Lipid Nanoparticle Complexes Encoding for Viral RNA Polymerase Region and Protein Antigen In force · Medium confidence | In force | Medium confidence | |
| US 11,458,209 | Compositions and Methods for Delivery of Nucleic Acid-Lipid Nanoparticle Complexes Encoding for Viral RNA Polymerase Region and Protein Antigen In force · Medium confidence | In force | Medium confidence | |
| US 11,534,497 | Compositions and Methods for Delivery of RNA In force · Medium confidence | In force | Medium confidence | |
| US 11,559,584 | Compositions and Methods for Delivery of RNA In force · Medium confidence | In force | Medium confidence | |
| US 11,648,321 | Compositions and Methods for Delivery of RNA In force · Low confidence | In force | Low confidence | |
| US 11,648,322 | Compositions and Methods for Delivery of RNA In force · Low confidence | In force | Low confidence | |
| US 11,654,200 | Compositions and Methods for Delivery of RNA In force · Medium confidence | In force | Medium confidence | |
| US 11,679,163 | Compositions and methods for delivery of RNA In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 abandoned · 5 no status recorded